{
    "Symbol": "LLY",
    "AssetType": "Common Stock",
    "Name": "Eli Lilly and Company",
    "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.",
    "CIK": "59478",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US",
    "OfficialSite": "https://www.lilly.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "808942698000",
    "EBITDA": "15501900000",
    "PERatio": "110.1",
    "PEGRatio": "0.831",
    "BookValue": "15.06",
    "DividendPerShare": "4.86",
    "DividendYield": "0.0059",
    "EPS": "8.16",
    "RevenuePerShareTTM": "43.23",
    "ProfitMargin": "0.189",
    "OperatingMarginTTM": "0.391",
    "ReturnOnAssetsTTM": "0.137",
    "ReturnOnEquityTTM": "0.593",
    "RevenueTTM": "38922801000",
    "GrossProfitTTM": "21911600000",
    "DilutedEPSTTM": "8.16",
    "QuarterlyEarningsGrowthYOY": "0.682",
    "QuarterlyRevenueGrowthYOY": "0.36",
    "AnalystTargetPrice": "1003.35",
    "AnalystRatingStrongBuy": "7",
    "AnalystRatingBuy": "16",
    "AnalystRatingHold": "5",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "110.1",
    "ForwardPE": "39.06",
    "PriceToSalesRatioTTM": "20.78",
    "PriceToBookRatio": "58.9",
    "EVToRevenue": "21.18",
    "EVToEBITDA": "73.41",
    "Beta": "0.416",
    "52WeekHigh": "972.53",
    "52WeekLow": "543.96",
    "50DayMovingAverage": "898.91",
    "200DayMovingAverage": "799.11",
    "SharesOutstanding": "900426000",
    "DividendDate": "2024-09-10",
    "ExDividendDate": "2024-08-15"
}